Nantahala Capital Management’s Abivax ABVX Stock Holding History

Nantahala Capital Management’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.8M	Sell	133,759 -3,478	-3%	-$394K	0.59%	48
2026 Q1	$15.3M	Sell	137,237 -15,998	-10%	-$1.89M	0.56%	47
2025 Q4	$20.7M	Sell	153,235 -404,329	-73%	-$44.1M	0.68%	31
2025 Q3	$47.3M	Sell	557,564 -925,430	-62%	-$56.7M	1.64%	12
2025 Q2	$11.3M	Hold	1,482,994	–	–	0.44%	48
2025 Q1	$9.27M	Buy	1,482,994 +46,947	+3%	+$318K	0.37%	43
2024 Q4	$10.5M	Buy	1,436,047 +450,413	+46%	+$4.15M	0.45%	44
2024 Q3	$11.4M	Hold	985,634	–	–	0.57%	34
2024 Q2	$13M	Sell	985,634 -24,400	-2%	-$349K	0.76%	23
2024 Q1	$14.4M	Hold	1,010,034	–	–	0.83%	28
2023 Q4	$10.8M	Buy	+1,010,034	New	+$10.3M	0.65%	34

Other funds holding ABVX

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Jupiter Topco New York $245B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nantahala Capital Management's ABVX Position: Q2 2026 in Review

Nantahala Capital Management reduced its Abivax (ABVX) stake by 2.5% in Q2 2026, selling an estimated $394K and leaving 133,759 shares worth $17.8M. The position accounts for 0.59% of the portfolio, ranked #48.

Nantahala Capital Management first reported a position in ABVX in Q4 2023 and has held it in 11 quarters since. The position peaked at $47.3M in Q3 2025. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

Nantahala Capital Management held 133,759 shares of Abivax worth $17.8M as of Q2 2026.
Nantahala Capital Management sold 3,478 Abivax shares in Q2 2026, an estimated $394K.
Abivax made up 0.59% of Nantahala Capital Management's portfolio in Q2 2026, its #48 holding.
Nantahala Capital Management first reported a position in Abivax in Q4 2023 and has held it in 11 quarters since.
Nantahala Capital Management's Abivax position peaked at $47.3M in Q3 2025.
302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.